[1]
Sahai, R., Sharma, T., Dhasmana, D.C. and Kaeley, N. 2018. Comparative efficacy and safety of DPP-4 inhibitors and α-glucosidase inhibitors as add on therapy in type 2 diabetes. International Journal of Basic & Clinical Pharmacology. 7, 4 (Mar. 2018), 707–713. DOI:https://doi.org/10.18203/2319-2003.ijbcp20181173.